The SUNY Distinguished Professor and world-renowned neurosurgeon best known for changing the way stroke patients are treated died Oct. 5.
Elad I. Levy, MD, MBA, will present results of the clinical trial that assessed the safety of Synchron’s endovascular brain-computer interface in people with severe paralysis at the Congress of Neurological Surgeons.
Projects focus on cancer therapies, robotic clot removal catheters, and mRNA vaccines, among other technologies
Elad I. Levy, MD, MBA, has been awarded the Ralph G. Dacey Jr. Medal for Outstanding Cerebrovascular Research.
